Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand


Autoria(s): Trubiano, J.A.; Cheng, A.C.; Korman, T.M.; Roder, C.; Campbell, A.; May, M.L.A.; Blyth, C.C.; Ferguson, J.K.; Blackmore, T.K.; Riley, T.V.; Athan, E.
Data(s)

01/04/2016

Resumo

The incidence of Clostridium difficile infection (CDI) continues to rise, whilst treatment remains problematic due to recurrent, refractory and potentially severe nature of disease. The treatment of C. difficile is a challenge for community and hospital-based clinicians. With the advent of an expanding therapeutic arsenal against C. difficile since the last published Australasian guidelines, an update on CDI treatment recommendations for Australasian clinicians was required. On behalf of the Australasian Society of Infectious Diseases, we present the updated guidelines for the management of CDI in adults and children.

Identificador

http://hdl.handle.net/10536/DRO/DU:30084754

Idioma(s)

eng

Publicador

Wiley

Relação

http://dro.deakin.edu.au/eserv/DU:30084754/roder-australasiansocofinfectious-2016.pdf

http://www.dx.doi.org/10.1111/imj.13027

Direitos

2016, Royal Australasian College of Physicians

Palavras-Chave #Clostridium difficile #treatment #faecal microbiota transplant (FMT) #vancomycin #metronidazole #fidaxomicin
Tipo

Journal Article